Search by Drug Name or NDC

NDC 51672-4025-03 Amiodarone Hydrochloride 200 mg/1 Details

Amiodarone Hydrochloride 200 mg/1

Amiodarone Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., Inc.. The primary component is AMIODARONE HYDROCHLORIDE.

MedlinePlus Drug Summary

Amiodarone is used to treat and prevent certain types of serious, life-threatening ventricular arrhythmias (a certain type of abnormal heart rhythm when other medications did not help or could not be tolerated. Amiodarone is in a class of medications called antiarrhythmics. It works by relaxing overactive heart muscles.

Related Packages: 51672-4025-03
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Amiodarone

Product Information

NDC	51672-4025
Product ID	51672-4025_74e1d323-cd6f-41c3-9b5c-0f40e7acf27c
Associated GPIs	35400005000305
GCN Sequence Number	000266
GCN Sequence Number Description	amiodarone HCl TABLET 200 MG ORAL
HIC3	A2A
HIC3 Description	ANTIARRHYTHMICS
GCN	10920
HICL Sequence Number	000083
HICL Sequence Number Description	AMIODARONE HCL
Brand/Generic	Generic
Proprietary Name	Amiodarone Hydrochloride
Proprietary Name Suffix	n/a
Non-Proprietary Name	Amiodarone Hydrochloride
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	200
Active Ingredient Units	mg/1
Substance Name	AMIODARONE HYDROCHLORIDE
Labeler Name	Taro Pharmaceuticals U.S.A., Inc.
Pharmaceutical Class	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA075424
Listing Certified Through	2024-12-31

Package

NDC 51672-4025-03 (51672402503)

Pricing Information	N/A
NDC Package Code	51672-4025-3
Billing NDC	51672402503
Package	1000 TABLET in 1 BOTTLE (51672-4025-3)
Marketing Start Date	2001-03-30
NDC Exclude Flag	N